Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Susan Utley

Nurse Practitioner Nashville, TN Nurse Practitioner

NPI 1366525388 CMS profile 11153323

250 25Th Ave North, Suite 100, Nashville, TN 37203

Open in the dashboard

General payments

$194,006

681 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Susan Utley of Nashville, TN is reported in the CMS Open Payments database as having received $194,006 across 681 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $39,356 194
2024 General $31,653 143
2023 General $52,322 175
2022 General $43,817 111
2021 General $26,859 58

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Susan Utley
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Susan Utley were reported at $39,356. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Susan Utley Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $26,859 $135 $40–$426 $132
2022 $43,817 $152 $48–$470 $149
2023 $52,322 $166 $54–$529 $160
2024 $31,653 $173 $55–$556 $164
2025 $39,356 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AstraZeneca Pharmaceuticals LP $69,393 133 payments
  2. Exelixis Inc. $46,708 112 payments
  3. Seattle Genetics, Inc. $18,048 40 payments
  4. Astellas Pharma US Inc $13,744 26 payments
  5. BeiGene USA, Inc. $10,594 37 payments
  6. EMD Serono, Inc. $7,458 20 payments
  7. Epizyme, Inc., $6,412 14 payments
  8. Pfizer Inc. $6,097 12 payments
  9. Amgen Inc. $5,958 14 payments
  10. Janssen Biotech, Inc. $1,129 22 payments
  11. Other $8,466 251 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $111,876 89 payments
  2. Travel and Lodging $31,773 130 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $19,978 12 payments
  4. Food and Beverage $19,269 429 payments
  5. Honoraria $6,160 11 payments
  6. Consulting Fee $4,125 2 payments
  7. Education $826 8 payments
Products named General payments · program years 2021–2025
  1. CALQUENCE $47,867 79 payments
  2. CABOMETYX Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) $31,111 71 payments
  3. PADCEV Oncology $17,891 37 payments
  4. CABOMETYX Oncology $15,309 38 payments
  5. IMFINZI $15,088 23 payments
  6. PADCEV Oncology $13,525 23 payments
  7. BRUKINSA $10,610 38 payments
  8. TAZVERIK $6,536 15 payments
  9. Padcev Oncology $6,015 7 payments
  10. TAGRISSO $5,753 13 payments
  11. Other $22,047 383 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

109

Median for Nurse Practitioner: 389

Drug cost

$2,421

Median for Nurse Practitioner: $21,885

Branded share of claims

40.4%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 24 $845
Anastrozole Generic 15 $728
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 20 $424
Tamoxifen Citrate Generic 12 $295
Prednisone Generic 13 $75
Zolpidem Tartrate Generic 25 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 56 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
CABOMETYX
  • Exelixis Inc. $9,470
$9,470 — —
Padcev
  • PFIZER INC. $3,088
  • Astellas Pharma US Inc $2,603
$5,692 — —
IMFINZI
  • AstraZeneca Pharmaceuticals LP $5,161
$5,161 — —
BRUKINSA
  • BeiGene USA, Inc. $3,495
$3,495 — —
CALQUENCE
  • AstraZeneca Pharmaceuticals LP $1,167
$1,167 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 56 with Patron

Records

681 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record